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ABSTRACT
This thesis is devoted to designing and applying advanced algorithmical and sta-
tistical tools for analysis of NGS data related to cancer and infection diseases. NGS data
under investigation are obtained either from host samples or viral variants. Recently, ran-
dom peptide phage display libraries (RPPDL) were applied to studies of host’s antibody
response to different diseases. We study human antibody response to breast cancer and
mouse antibody response to Lyme disease by sequencing of the whole antibody reper-
toire profiles which are represented by RPPDL. Alternatively, instead of sequencing im-
mune response NGS can be applied directly to a viral population within an infected host.
Specifically, we analyze the following RNA viruses: the human immunodeficiency virus
(HIV) and the infectious bronchitis virus (IBV). Sequencing of RNA viruses is challenging
because there are many variants inside population due to high mutation rate.
Our results show that NGS helps to understand RNA viruses and explore their in-
teraction with infected hosts. NGS also helps to analyze immune response to different
diseases, trace changing of immune response at different disease stages.
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1PART 1
INTRODUCTION
Next generation sequencing (NGS) refers to such modern high-throughput sequenc-
ing technologies as Illumina sequencing, Roche 454 sequencing, Ion torrent and SOLiD
sequencing. Technological revolution allowed to sequence DNA and RNA much more
quicker and cheaper than previously used Sanger sequencing. Millions of reads now
can be processed in parallel. Table 1.1 provides specifications of different sequencing
technologies. NGS also needs significantly less DNA and is more reliable than Sanger
sequencing. However, NGS reads are much shorter which requires assembly the vast
amount of sequences that are generated. They also prone to high error rates and need
additional error correction.
This work is concentrated on analysis of NGS data related to cancer and infection
diseases. In this case NGS data represent either antibody response to a disease or a viral
population within the infected host. Both types of the data have their own drawbacks
and require the development of special methods for analysis.
Table 1.1 Comparison of different sequencing technologies.
manufacturer avg read length avg read count avg error rate paired reads
Sanger 1000bp 96 0.001% No
Roche/454 450bp 1M 1.0% Yes
Illumina 150bp 500M 0.1% Yes
Ion Torrent 300bp 6M 1.0% Yes
SOLiD 50bp 1400M 0.1% Yes
1.1 Analysis of viral NGS data
RNA viruses, in which the genetic information is stored in the form of RNA, are
the most abundant group of subcellular parasites infecting animals, plants, and bacteria.
2They cause such severe diseases as hepatitis, viral encephalitis, yellow fever, and AIDS.
Distinctive features of RNA virus replication include high mutation rates, high yields, and
short replication times [2]. As a result, RNA viruses replicate as a dynamic and complex
mutant group, called viral quasispecies.
NGS presents a novel opportunity for understanding RNA viruses, particularly, their
evolution, drug resistance and immune escape. It allows to analyze a great number of vi-
ral variants from infected patients offering a deep coverage of genomic data [3]. Even low
frequency variants may have a great interest, for example, affect virulence [4]. Although
NGS provides cost-effective access to high-throughput data, inferring the viral genetic
diversity of a mixed sample from sequencing data is still a challenging task. The reasons
lie in difficulties of sample preparation and sequencing errors, short read length and, in
particular, an incomplete a priori knowledge of existing viruses and their diversity [5].
Estimating viral genetic diversity and reconstructing the individual haplotype sequences
relies on both error correction and read assembly [5].
1.1.1 Error correction of viral NGS data
NGS provides reads with very deep coverage. However, the relatively high error rate
limits the ability to analyze population diversity directly. The error correction problem
involves identifying and correcting errors in reads introduced during sequencing. The
main purpose of error correction of viral NGS data is to discriminate between artifacts
and actual sequences. This task is complicated by the fact that quasispecies contains close
variants and some of them may have low frequency.
Computer-assisted studies of viruses is a neglected area of research. The attention of
bioinformaticians to this challenging field is far from sufficient. There is a lack of error
correction methods for viral NGS data. In fact, there are only a couple of existing tools -
KEC [6] and ShoRAH [7].
KEC stands for K-mer-based error correction. This algorithm is for viral amplicons
based on k-mers. It starts from calculating of k-mers and their frequencies. Then it de-
3termines the count threshold which distinguish "correct" or high count k-mers from low
count k-mers contained errors. Finally, it finds error regions of the reads where all k-mers
have low count and corrects the errors in those regions [6].
ShoRAH stands for Short Reads Assembly into Haplotypes. It is a genome assembly
tool which include also its own error correction. It corrects sequencing errors by cluster-
ing all reads that overlap the same region of the genome of length approximately equal to
the read length. The consensus sequence of each cluster represents the original haplotype
from which the erroneous reads are obtained [7].
1.1.2 Assembly of viral NGS data
NGS does not directly sequence viral genomes describing a viral population. Instead,
it produces relatively short reads that should be assembled into population variants. The
problem formulation is following: given a collection of NGS reads from a viral sample,
variants and their relative frequencies inside the sample need to be reconstructed. The
problem is challenging because variants are similar to each other, there are overlapped
regions. The decision should be made which read belongs to which variant. Due to the
great diversity and the high mutation rates, there is a lack of a suitable reference genome
which is a major hindrance for many viral quasispecies assembly approaches. A brief
description of some popular viral quasispecies assembly tools are given below.
The first publicly available tool for reconstructing a viral quasispecies was ShoRAH
[7]. The analysis with ShoRAH includes four major steps: alignment; 2) error correction;
3) haplotype reconstruction and 4) frequency estimation. The reconstruction method em-
ploys a parsimony principle and computes a minimal set of haplotypes that explains all
reads in the dataset. Once the putative variants have been assembled, their relative abun-
dances are computed using an Expectation-Maximization (EM) algorithm. ShoRAH can
be run on NGS shotgun data or single amplicon data [7].
Another assembly tool is the Viral Spectrum Assembler, or ViSpA [8]. It reconstructs
quasispecies by constructing a weighted read-overlap graph. Similarly to ShoRAH,
4ViSpA utilizes an EM algorithm for estimating variant frequencies. Originally it was de-
signed for NGS shotgun data, but in theory it could be applied to amplicon-based data as
well.
QuRe [9] is a tool for viral Quasispecies Reconstruction, specifically developed to
analyze long read (>100 bp) NGS data such as Roche 454 Life Sciences. It performs align-
ments of sequence fragments against a reference genome, finds an optimal division of the
genome into sliding windows based on coverage and diversity and attempts to recon-
struct all the individual sequences of the viral quasispecies-along with their prevalence-
using a heuristic algorithm, which matches multinomial distributions of distinct viral
variants overlapping across the genome division [9].
QuasiRecomb [4] is another assembly tool. It uses a hidden Markov model (HMM)
to generate viral populations, i.e., haplotype distributions, and their probing by means
of NGS. In this model, the haplotypes are originating from a small number of generat-
ing sequences via recombination, described as switch of state in the HMM that selects
from which sequence the haplotype derives, and mutation, described by position-specific
probability tables for the generating sequences. It is suitable for amplicon and shotgun
sequencing projects [4].
SAVAGE [10] is a new computational tool for reconstructing individual haplotypes of
intrahost virus strains without the need for a high-quality reference genome. It constructs
an overlap graph directly from the patient sample reads. It is the first approach for de
novo assembly of viral quasispecies based on overlap graphs.
1.2 Phage display data processing for immune response analysis
Instead of direct sequencing of viral population within an infected host, a disease can
be explored by sequencing of the host’s immune response. The immune system protects
the body from possibly harmful substances by recognizing and responding to antigens.
Antigens are substances (usually proteins) on the surface of cells, viruses, fungi, or bacte-
ria. Serum antibodies are valuable source of information on the health state of an organ-
5ism [11]. Recently, random peptide phage display libraries (RPPDL) together with NGS
were applied to studies of antibody response to different diseases.
1.2.1 Phage display
Phage display is a laboratory technique for the study of protein-protein, protein-
peptide, and protein-DNA interactions. It uses viruses that infect bacteria (bacteriophage
or, simply, phage) to connect proteins with the genetic information encoded them. Phage
display was proposed by George P. Smith in 1985 [12]. The genome of a bacteriophage
contains the gene that encodes the phage coat protein. In this technique, a gene encoding
a protein (or peptide) of interest is inserted into a virus coat protein gene, causing the
phage to "display" the protein on its outside. The pool of phages with different proteins
of interest forms a library. A library can be screened against other proteins, peptides or
DNA sequences, in order to detect interaction between the displayed protein and those
other molecules. The process is called in vitro screening. The phage display library is
mixed with the desired target DNA sequences or proteins. After some time allowing the
phage to bind the mix is washed. All phage-displaying proteins that are not interacted
are washed away. Attached phage may be eluted and amplified in bacterial hosts. The
procedure can be repeated several times. Then the DNA withing the phage is sequenced
using NGS.
Since an antibody recognizes not the whole antigen but 4-7 critical amino acids
within the antigenic determinant (epitope), the whole serum antibody repertoire profile
can be represented by RPPDL (Figure 1.1). In RPPDL, a DNA sequence encoding some
random peptide is inserted into a phage coat gene which leads to displaying of this pep-
tide on the phage outside. Ph.D.TM-7 Phage Display Peptide Library Kit is an example
of such library. It is a library of almost all possible 7-mer peptides and commercially
available from New England Biolabs (NEB). After mixing the library with a blood serum,
DNA withing the phage interacted with antibody is sequenced and translated into pep-
tide. Obtained peptides represent a mimotope profile of a serum sample - mimic of all
6F
R
D
K
c
E
P
A
D
Q
V
N
P
R
Y
L
A
C
E
F
WPhage 
coat
Phage 
DNA
Peptide 
coding  
sequence
Peptide
Figure 1.1 Schematic representation of random peptide phage display library
epitopes recognized by all antibodies contained in the serum. Mimotope profiles of dif-
ferent samples can be studied and compared with each other.
RPPDL together with the NGS technology make possible to identify all the epitopes
recognized by all antibodies contained in the blood serum using one run of the sequenc-
ing machine. However, this approach has one drawback. The obtained peptide profiles
can consist of millions of sequences. A significant fraction of these sequences is not re-
lated to the repertoires of antibody specificities, but produced by nonspecific binding and
preferential amplification in bacteria. The presence of these ”parasitic” sequences pro-
duces a lot of noise and complicates the analysis of immune response. Considering that
the affinity selected sequences can be clustered into the groups of similar sequences with
shared consensus motifs, while the parasitic sequences are usually represented by single
7copies. Motifs are stable to parasites.
1.2.2 Mimotope motifs
A group of peptides with a common sequence pattern forms a motif. An alignment
of peptides forming a motif contains conserved positions. A motif can be represented as
a position weight matrix which summarizes the amino acid preferences for each column
of the alignment. Each value in this matrix corresponds to frequency of an amino acid in
current position. Alternatively, in [13] it was proposed to represent a given alignment by
a log-odds weight matrix. A log-odds weight matrix is calculated as log2(pA,j/qA), where
pA,j is the frequency of amino acid A at position j, and qA is the background frequency
of A. The quality of a motif can be measured by information content (IC) or Kullback-
Leibler divergence (KLD). The IC says how different a given position weight matrix is
from a uniform distribution. IC can be calculated as IC = log220 +
∑
A,j pA,j ∗ log2(pA,j).
Often, it is more useful to calculate the IC with the background letter frequencies of the
sequences you are studying rather than assuming equal probabilities of each amino acid.
Thus, IC corresponds to the KLD or relative entropy. The equation in this case becomes:
KLD = −
∑
A,j pA,j ∗ log2(pA,j/qA). The KLD allows measuring the information gain of
an observed amino acid distribution compared with a background distribution (the fre-
quency of each amino acid in random protein sequences).
One of the examples of mimotope motifs’ application is the early detection of cancer.
Circulating auto-antibodies produced by the patient’s own immune system after expo-
sure to cancer proteins are promising bio-markers for the early detection of cancer. In this
case, motifs represent cancer bio-markers [14]. Another example is finding epitopes of
Borrelia burgdorferi bacteria [15]. This bacteria causes Lyme disease - the most prevalent
tick-borne illness in North America and Europe. Lyme disease is problematic because
early diagnosis is easily missed due to flu-like symptoms, which only transiently appear
in humans during an early stage of disease [16]. When missed and, therefore left un-
treated, Lyme disease becomes chronic, presenting itself as skin lesions, arthritis, cardi-
8tis, and occasionally followed by nervous system involvement [17]. No preventable or
therapeutic vaccine is currently available. In this case, mimotope motifs correspond to
epitopes.
1.2.3 Finding mimotope motifs
The are two main approaches for finding mimotope motifs. First one is based on
clustering, second is based on BLAST alignment.
If we consider a motif as a cluster formed by peptides with the center represented
by a consensus sequence then construction of a motif corresponds to a difficult cluster-
ing problem with many closely located centers. The radius of a cluster may exceed the
distance from one cluster to another one. Recently, several software tools based on clus-
tering were proposed for finding mimotope motifs. MUltiple Specificity Identifier (MUSI)
[18] relies on mixture model optimization. The algorithm behind MUSI is based on the
idea of fitting several linear probabilistic models (in this case, position weight matrices)
to a set of sequences to optimally describe the different specificity classes. It uses a Max-
imum Likelihood approach with Dirichlet priors for fitting. GibbsCluster is another tool
proposed in [13] and based on Gibbs sampling. Both tools try to be versatile and allow
for peptide data from any biological source to be processed, but may require some prior
data knowledge, such as the number of clusters to identify. They perform well on smaller
datasets of up to thousands of sequences, but not million of sequences. Finally, Hammock
[19] is a hidden Markov model-based peptide clustering algorithm. Hammock uses pro-
file HMMs for presise computational representation of sequence motifs and is based on
the idea of progressive cluster growth. Unlike two other tools, it is able to process very
large datasets, to identify multiple distinct motifs within one dataset and no prior data
knowledge is required.
A method for finding mimotope motifs based on protein-protein BLAST alignment
was proposed in [11]. The idea of the method is following. BLAST aligns sample pep-
tides to interesting proteins (for example, all proteins of the organism). The goal is to
9retrieve proteins that have multiple matches to different peptides. The probability for a
protein to have multiple matches to different peptides due to a chance is proportional to
the length of the protein [11]. So, each protein receives a score equaled to a number of
mapped peptides divided by the length of the protein. The proteins with the high scores
are considered as antigen candidates and positions on those proteins where the peptides
are mapped are epitope candidates. A group of peptides aligned to the same location on
a protein forms a mimotope motif.
1.3 RNA-seq data processing for immune response analysis
RNA-Seq is an approach to transcriptome profiling using NGS technologies. The
transcriptome is the complete set of transcripts in a cell, and their quantity, for a specific
developmental stage or physiological condition. RNA-Seq is the first sequencing-based
method that allows the entire transcriptome to be surveyed in a very high-throughput
and quantitative manner [20]. Depending on whether there is a disease in an organism
or not, the transcriptional activity of genes involved in immune response is different.
One particularly powerful advantage of RNA-Seq is that it can capture this difference.
Although, like other high-throughput sequencing technologies, RNA-Seq requires devel-
opment of special methods for data analysis.
Many variations of RNA-seq protocols and analyses have been published, but there is
still no optimal pipeline. In general, for a typical RNA-seq experiment, the major analysis
steps are quality control, read alignment with and without a reference genome, obtaining
metrics for gene and transcript expression, and approaches for detecting differential gene
expression [21]. Quality control for the raw reads involves the analysis of sequence qual-
ity, GC content, the presence of adaptors, overrepresented k-mers and duplicated reads
in order to detect sequencing errors, PCR artifacts or contaminations. Next, the analy-
sis involves the mapping of the reads onto the reference genome or transcriptome to infer
which transcripts are expressed. In case the organism does not have a sequenced genome,
the analysis first assembles reads into longer contigs and then treats these contigs as the
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expressed transcriptome to which reads are mapped back again for quantification. Then
the estimation of gene and transcript expression is done usually based on the number of
reads that map to each transcript sequence. Finally, the differential expression analysis
compares gene expression values among samples. Recent independent comparison stud-
ies have demonstrated that the choice of the method (or even the version of a software
package) can markedly affect the outcome of the analysis and that no single method is
likely to perform favorably for all datasets [21].
1.4 Contributions
The main contributions are:
• The-state-of-the-art error correction programs were compared on HIV NGS data.
• The reconstructed IBV quasispecies were validated by comparing them with IBV
variants sequenced by Sanger.
• A novel method for motif identification in mimotope profile (CMIM) based on
CAST clustering [22]. The statistical analysis is performed to distinguish between
cancer patients and controls and find cancer specific motifs.
• A novel method for motif identification in mimotope profile based on k-means clus-
tering.
• Application of the BLAST alignment method for finding motifs for epitopes to Lyme
disease data. The antibody response to known antigens and VlsE protein responsi-
ble for persistence of the infection between days 28 and 70 of the disease has been
compared.
• Application of RNA-seq data analysis tools for measuring human immune response
to wild and vaccine rubella virus.
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1.5 Future work
We plan to apply pathways analysis to RNA-seq rubella data.
1.6 Roadmap
The rest of the dissertation is organized as follows. Chapter 2 presents analysis of
viral NGS data. First, the-state-of-the-art error correction methods are benchmarked on
HIV NGS data. Then different methods for viral quasispecies reconstruction are com-
pared. The reconstructed IBV quasispecies were validated by comparing them with IBV
variants sequenced by Sanger. In Chapter 3 we analyze NGS data representing immune
response to breast cancer and Lyme disease though mimotope profiles. In the first part,
two novel methods are proposed for identification of motifs in mimotope profiles based
on CAST and k-means clustering. In the second part, motif finding method based on
BLAST alignment was applied to detect any significant changes in antibody repertoires
on early and late stages of Lyme disease. In chapter 4 we applied RNA-seq data analysis
pipeline for for measuring human immune response to wild and vaccine rubella virus.
Our plans for future work are discussed in Chapter 5.
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PART 2
ANALYSIS OF VIRAL NGS DATA
RNA virus has RNA as its genetic material. Notable examples include HIV, HCV and
influenza. It is difficult to make effective vaccines against RNA viruses because they have
high mutation rates compared to DNA viruses. Thus, mutation rates vary between 10−4
and 10−6 per nucleotide [23]. Distinctive features of RNA virus replication include high
mutation rates, high yields, and short replication times [2]. As a result, RNA viruses repli-
cate as a dynamic and complex mutant group, called viral quasispecies. A quasispecies
refers to a population of genetically related viruses that are closely distributed around a
consensus sequence [23].
RNA viruses have high genomic diversity within an infected host. It effects many
clinically important phenotypic traits such as escape from vaccine-induced immunity,
virulence, and response to antiviral therapies [24]. Sequencing technologies must be sen-
sitive enough in order to accurately characterize an intra-host RNA virus population virus
population [25, 26]. NGS technologies offer deep coverage of genomic data in the form
of millions of sequencing reads allowing to capture rare variants [27]. But the full pic-
ture of viral diversity in a population remains undiscovered due to errors produced by
sequencing platforms. The presence of sequencing errors makes it difficult to distinguish
between variants and sequencing errors. Additionally, low viral population variability
(i.e., pairs of individual viral genomes that have small genetic distance) and the presence
of individual variants having low abundance complicates accessing viral diversity and
assembling full-length viral variants [28].
Current sequencing technologies use different underlying chemistry and offer trade-
offs among throughput, read length and cost [27]. Although the sequencing platforms
can potentially detect point-mutations, error rates may result in false positive SNV calls
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or wrong genome variant sequences. Current assembly methods [8, 7, 9, 29, 30] are not
able to differentiate true biological mutations from sequencing artifacts, thus significantly
limiting the possibility of a method to assemble the underlying viral population. Compu-
tational error correction approaches are able to partially correct the sequencing error but
they are not well suited for mixed viral samples and may lead to filtering out true biolog-
ical mutations. As the result the low abundant variants remain undiscovered. Additional
difficulty is the genomic architecture of viruses. Long conserved regions shared across
viral population introduce ambiguity in the assembly process, because they may have
multiple cross-overs. In contrast to repeats in genome assembly conserved regions may
be phased based on relative abundances of viral variants. Estimating viral genetic diver-
sity and reconstructing the individual haplotype sequences relies on both error correction
and read assembly [5].
2.1 Error correction of viral NGS data
2.1.1 Introduction
NGS provides reads with very deep coverage. However, the relatively high error
rate limits the ability to analyze population diversity directly. The main purpose of error
correction of viral NGS data is to discriminate between artifacts and actual sequences.
This task is complicated by the fact that quasispecies contains close variants and some of
them may have low frequency.
In this work, different error correction tool were compared. As far as not many re-
search groups focusing on viruses, general methods developed for human sequencing
data and metagenomics data were also considered. For evaluation a high-fidelity se-
quencing protocol was used. It eliminated errors from sequencing data. The protocol,
known as the Safe-Sequencing System (”safe-SeqS”), has been proposed in [31] and ap-
plied to detect rare somatic mutations, but its application on detecting rare viral muta-
tions has been neglected.
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2.1.2 Materials and methods for error correction
We used an Illumina HiSeq HIV paired-end dataset. A special library preparation
protocol based on safe-SeqS that eliminates sequencing errors during the de-multiplexing
step was applied. In [28] the authors proposed the application of safe-SeqS on detecting
rare viral mutations. The protocol involved two steps. The first step was the assignment
of a unique barcode sequence to each DNA fragment. The second step was the amplifica-
tion of each tagged fragment. After sequencing the reads belonging to the original frag-
ment were clustered based on the barcode. Then consensus sequence of each cluster was
calculated with condition that the most popular nucleotide at a position had frequency
at least 0.9, otherwise the whole barcode cluster was disregard. Thus every sequenced
position of the fragment would have multiple independent evidence supporting highly
accurate consensus read. We deleted sequence fragments of 13bp represented barcodes
from consensus reads and considered the reads as ground truth (further referred to as
barcode-corrected reads). We also deleted barcode sequences from the original reads and
considered the reads as test data for error correction methods (further referred as original
reads).The length of barcode-corrected and original reads after barcode deletion became
87bp.
Computer-assisted studies of viruses is a neglected area of research. The attention of
bioinformaticians to this challenging field is far from sufficient. There is a lack of error
correction methods for viral NGS data. For this reason together with error correction
methods developed for viruses we considered methods developed for human sequencing
data and metagenomics data. We ran 5 error correction tools: BLESS V1.02 [32], Fiona
V0.2 [33], Pollux V1.0.2 [34], K-mer-based error correction (KEC) [6] and Short Reads
Assembly into Haplotypes (ShoRAH) [7]. All tools were downloaded and installed on
our server. Brief descriptions of tools with parameters we used are given in this section.
BLESS stands for BLoom-filter-based Error correction Solution for high-throughput
Sequencing reads and belongs to the k-mer spectrum-based method. It uses a single
minimum-sized Bloom filter [35], and is also able to tolerate a high false-positive rate, al-
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lowing to correct errors with a reduce memory usage comparing to other methods. BLESS
can extend reads to correct errors at the end of reads as accurately as other parts of the
reads. Another feature of BLESS is ability to handle repeats in genome and long k-mers
which leads to high accuracy. BLESS accepts single-end or paired-end reads as input.
Another parameter is k-mer length. We chose it equal to 20 based on empirical formula
provided by the tool’s authors.
Fiona developed for different organisms with short or long genomes. It uses an effi-
cient implementation of suffix arrays to detect read overlaps with different seed lengths
in parallel. The developers of Fiona claims that it is an accurate error-correction method
able to handle substitution, insertion and deletion errors equally well and can be applied
to any sequencing technology. It is known that Illumina technology produces mostly
substitution errors [36]. We ran a special version of Fiona for Illumina reads that corrects
indels but only considers hamming pairwise read distance. In fact, Fiona works only on
single-end reads, so we mixed all pared-end reads into one data set. The only parameter
should be set was the length of the genome. We used the length of Gag/Pol 3.4 Kb HIV
region.
Pollux is a tool that corrects errors introduced by Illumina, Ion Torrent, and Roche
454 sequencing technologies and can be applied to single- or mixed-genome data. The
method approaches the problem of error correction using k-mers. During error correction
Pollux scans reads and divides them into k-mers of length 31. It counts the number of
occurrences of each observed k-mer. Then it scans reads again and generates a k-mer
depth profile for each read, using this information to correct the k-mer profile [34]. One
of the reason we tested Pollux because it could be applied to mixed genomes. We ran
Pollux on our data with default parameters.
KEC is error correction algorithm for viral amplicons based on k-mers. It starts from
calculating of k-mers and their frequencies. Then it determines the count threshold which
distinguish "correct" or high count k-mers from low count k-mers contained errors. Fi-
nally, it finds error regions of the reads where all k-mers have low count and corrects the
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errors in those regions [6]. KEC needs k-mer length as a parameter. We decided to use
default 25. Running KEC on original reads, we faced some difficulties. First, KEC does
not work on paired-end reads, so we mixed all reads together and considered them as
single. Second, KEC could not handle all reads. We considered only reads assigned to
barcode clusters with the consensus (true read) mapped to Gag/Pol 3.4 Kb HIV region.
The reads were sorted according the position of their cluster consensus in Gag/Pol. Then
the reads were divided into groups of approximately 5 million reads. KEC was run on
each of those groups separately.
ShoRAH was developed to correct sequencing errors and to estimate the population
structure of a heterogeneous sample. It corrects sequencing errors by clustering all reads
that overlap the same region of the genome of length approximately equal to the read
length. The consensus sequence of each cluster represents the original haplotype from
which the erroneous reads are obtained /citeshorah. ShoRAH should be run on aligned
reads. So, we used the result of BWA-MEM mapping of original reads on Gag/Pol 3.4 Kb
HIV region with default parameters.
2.1.3 Results
Datasets
We benchmark the performance of error correction tools on a 3.4 kb region of
HIV spanning the Gag/Pol genes. The total number of original paired-end reads was
106,667,644. The original reads having identical 13 bp barcodes were grouped together in
so-called barcode clusters. As a result of safe-SeqS protocol 3,052,919 clusters left others
were disregarded. A consensus sequence was identified for each cluster and considered
as a ground true read. In Figure 2.2 the size of a barcode cluster shows the number of
original reads assigned to it. About 52% of all clusters consisted of 2 reads; about 31%
of clusters consisted of 3, 4 or 5 reads; 4% - 6..10 reads; 5.5% - 11..20 reads; 4% - 21..30
reads; 1% - 31..40 reads and others were less than 0.2%. Thus, 0.12% of clusters consisted
of more than 1000 reads and 0.02% consisted of more than 2000 reads. Maximum barcode
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size was 3178 reads.
Figure 2.1 Percentage of barcode clusters with size N.
Figure 2.2 The number of mapped barcode-corrected reads.
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All 6,105,838 forward and reverse parts of barcode-corrected reads (or 3,052,919
pairs) were mapped to Gag/Pol 3.4 Kb HIV region using BWA-MEM with default pa-
rameters, Mosaik with default parameters and Bowtie2 with the following parameters:
very-sensitive, -N 1, -a (see Figure 2.2 ). BWA-MEM mapped 3,327,717 reads (54.5%),
among them 2,880,818 reads where both ends were mapped (or 1,440,409 pairs), 446,899
reads where just one end was mapped. Mosaik mapped 2,748,821 reads (45%), among
them ,2155,756 reads where both ends were mapped (or 1,077,878 pairs), 593,065 reads
where just one end was mapped. Bowtie2 mapped 2,510,061 reads (41%), among them
1,929,344 reads where both ends were mapped (or 964,672 pairs); 580,717 reads where just
one end was mapped.
Figure 2.3 Overlapped barcode-corrected reads which are agree or do not agree in over-
lap. Red color - agree, blue - do not agree.
In Figure 2.3, according BWA-MEM 345,100 paired-end barcode-corrected reads have
overlap between forward and reverse parts. Among them 315,327 reads are agree in over-
lap (both ends are equal each other) and 29,773 do not agree. According Mosaik 222,760
reads have overlap, among them 222,765 agree and 4 do not agree. According Bowtie2
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208,237 reads have overlap, among them 208,174 agree and 63 do not agree.
Figure 2.4 Soft-clipped barcode-corrected reads.
In Figure 2.4, BWA-MEM produced 342,761 soft-clippings with the length 5nt or
greater, and 336,269 soft-clippings with the length 10nt or greater. Mosaik produced
17,498 soft-clippings with the length equal or greater than 5nt, and 1,942 soft-clippings
with the length equal or greater than 10nt. Bowtie2 did not produce any soft-clipping.
In Figures 2.5, 2.6, 2.7 the fragment length distribution of barcode-corrected reads
mapped by different aligners are represented.
In Figures 2.8, 2.9, 2.10 the number of SNPs in barcode-corrected reads according
different aligners is shown. The first chart represents the number of SNPs in all reads
with thresholds at least 1 SNP per read, at least 5 SNPs per read and at least 10 SNPs per
read. The second chart shows SNPs in overlapped reads, the third shows SNPs in not
overlapped reads. It may be noticed that BWA produces mostly alignments with more
than 10 SNPs per read.
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Figure 2.5 Fragment length distribution of barcode-corrected reads mapped by BWA-
MEM. Results are shown for the length from 0 bp to 700bp. The smallest fragment length
was 2bp, the biggest fragment length was 3440bp.
Figure 2.6 Fragment length distribution of barcode-corrected reads mapped by Mosaik.
Results are shown for the length from 0 bp to 700bp. The smallest fragment length was
73bp, the biggest fragment length was 3397bp.
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Figure 2.7 Fragment length distribution of barcode-corrected reads mapped by Bowtie2.
Results are shown for the length from 0bp to 700bp. The smallest fragment length was
77bp, the biggest fragment length was 3398bp.
Figure 2.8 Number of SNPs in barcode-corrected reads according BWA-MEM
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Figure 2.9 Number of SNPs in barcode-corrected reads according Mosaik
Figure 2.10 Number of SNPs in barcode-corrected reads according Bowtie2
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Results of error correction
We evaluated the performance of error correction tools BLESS, Fiona, Pollux, KEC,
and ShoRAH on correcting original reads to their true sequence. The consensus sequence
of the barcoded reads is considered as its true sequence and compared to the error cor-
rected read from each tool.
We compared the length of the error corrected reads from each tool. A majority of
reads generated from a tool are of length 87bps, which is the length of DNA segment se-
quenced in each read. Nevertheless, Fiona, Pollux, and KEC also generate error corrected
reads that are greater than 87 bps, indicating that these methods may have introduced
new bases in these reads during error correction. BLESS corrects 92.1% of the reads to
87 bps, while none of the reads have lengths greater than 87 bps, indicating that it only
trims the erroneous reads during error correction and does not adds additional bases to
the reads (Figures 2.11, 2.12, 2.13, 2.14, 2.15).
Figure 2.11 BLESS corrected reads length distribution.
Figures 2.16, 2.17, 2.18 represent the cumulative number of reads corrected by differ-
ent tools with different edit distance to the corresponding true reads divided by the total
number of original reads. BLESS was able to accurately correct 90% of original reads to
their consensus sequences. 95% of reads were corrected with no more than 1 mismatch.
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Figure 2.12 Fiona corrected reads length distribution.
Figure 2.13 Pollux corrected reads length distribution.
Fiona did not correct right any reverse original read. Fiona over corrected even those
original reads that were right. Totally Fiona was able to accurately correct 46% of original
reads, if count reverse and forward together. Pollux was able to accurately correct 70% of
original reads. 95% of reads contained no more than 3 mismatches.
ShoRAH returns a non-redundant set of reads that can be used as input for its vi-
ral reconstruction algorithm, thus this comparison cannot be performed for it. Running
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Figure 2.14 KEC corrected reads length distribution.
Figure 2.15 ShoRAH corrected reads length distribution.
KEC error correction tool on original reads we faced some difficulties. First, KEC does
not work on paired-end reads, so we mixed all reads together and considered them as
single. Second, KEC could not handle all reads. We considered only reads assigned to
barcode clusters with consensus (true read) mapped to Gag/Pol 3.4 Kb HIV region. The
number of such reads was 37,624,122. The reads were sorted according the position of
their cluster consensus in Gag/Pol. Then the reads were divided into groups of approxi-
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Figure 2.16 Cumulative number of reads corrected by BLESS with different edit distance
to the corresponding true reads divided by the total number of original reads.
Figure 2.17 Cumulative number of reads corrected by Fiona with different edit distance
to the corresponding true reads divided by the total number of original reads.
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Figure 2.18 Cumulative number of reads corrected by Pollux with different edit distance
to the corresponding true reads divided by the total number of original reads.
mately 5 million reads. Totally we obtained 7 such groups. KEC was run on each of those
groups separately. Finally all corrected reads were mixed together (37,041,305 reads).
KEC deleted some reads during error correction. After error correction most of the reads
(94.4%) did not change their size. KEC removed the name of original reads which made
read-by-read comparison with barcode-corrected reads impossible. Instead, we used an-
other method for evaluation. The total number of true barcode-corrected reads mapped
to Gag/Pol 3.4 Kb HIV region was 2,748,821 among them 132,816 reads were distinct.
The total number of original reads belonging to barcode clusters with mapped consensus
true reads was 37,624,122, among them 2,032,694 were distinct. KEC produced 37,041,05
corrected reads decreasing the original number of reads, the number of distinct reads was
604,591. Finally, BLESS output contained 37,624,122 reads with 1,907,275 distinct reads.
To evaluate the tools we considered only distinct reads. Among 604,591 distinct KEC
reads only 52,632 reads were equaled to the true reads which gives sensitivity of 0.396
and PPV of 0.087. Among 1,907,275 distinct BLESS reads only 95,015 reads were equaled
to the true reads which gives sensitivity of 0.715 and ppv of 0.05.
29
2.2 Assembly of viral NGS data
2.2.1 Introduction
RNA viruses are causing a significant burden on the health and productivity of agri-
culturally important animals since the rapid evolution of RNA viruses within infected
hosts is coupled in this context with frequent transmissions between animals, due to the
typically high animal density in production environments. Poultry farms are particu-
larly susceptible to viral infections, which cause significant economic losses worldwide
in terms of impaired growth, reduced egg production and quality, and even mortality.
In the U.S. where infections with virulent strains of Newcastle disease and highly
pathogenic avian influenza are not common, the infectious bronchitis virus (IBV) is con-
sidered the biggest single cause of economic loss. It infects the domestic fowl [37]. Be-
sides causing respiratory disease it may also replicate at many non-respiratory epithelial
surfaces. First described in the U.S. in 1930, IBV has undergone exponential population
growth [38] and is now distributed worldwide, with dozens of circulating serotypes that
may differ by as much as 25% in the amino acid sequence of the hypervariable region of
the spike glycoprotein.
As serotypes cross-protect poorly, chicken may get infected multiple times during
their lifetime. IBV infection of broilers retards growth while in layers it drops down egg
production. Young chicken may die directly from IBV infection, but a greater number die
due to secondary bacterial infections. Vaccination, most commonly with live attenuated
vaccines, is broadly used to control IBV disease but protection is short-lived and layers
have to be revaccinated multiple times during their lifespan, sometimes with different
serotypes.
Several IBV serotypes can co-circulate in a region, creating conditions for recombina-
tion between strains and resulting in complex evolution and epidemiology [39]. Cloning
and sequencing has been used to show that IBV variants exist in infected poultry [40] as
well as in several widely used commercial live attenuated vaccines [41]. Furthermore,
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McKinley et al.[41] has shown that attenuated live vaccines undergo in vivo selection fol-
lowing vaccination and can infect contact-exposed chicken. Coupled with significant field
persistence of Arkansas-type vaccine viruses [42], this reinforces the evidence that infec-
tious IBV strains can emerge from the evolution of attenuated live vaccines in commercial
flocks [43].
NGS is emerging as a key technology for quasispecies analysis. NGS does not di-
rectly sequence viral genomes describing a viral population. Instead, it produces rela-
tively short reads that should be assembled into population variants. Initial studies have
focused on using NGS to identify extremely low frequency drug-resistant variants in hu-
man patients chronically infected with HIV [44, 45, 46, 47, 48]. Just as PCR and automated
Sanger sequencing revolutionized molecular biology, NGS is expected to transform re-
search on phylodynamics of RNA viruses [49]. However, NGS analysis is challenging
due to the huge amount of data on one hand, and to the short read lengths and high er-
ror rates on another. Another challenge is that variants are close to each other, there are
overlapping regions. There should be decision which read belongs to which variant.
Many tools developed for Sanger reads do not work at all or have impractical run-
times when applied to NGS data. Even newly developed algorithms for de novo genome
assembly from NGS data are tuned for reconstruction of haploid genomes, and work
poorly when the sequenced sample contains a large number of closely related sequences,
as is the case in viral quasispecies. To address these shortcomings we evaluated recon-
struction flows for accurate reconstruction of viral quasispecies sequences and estimate
their frequencies from NGS data where it incorporates different error correction meth-
ods, aligners, and genome assemblers (ViSpA [8], and ShoRAH [7]), using different tun-
ing parameters. It should be noted some other recent genome reconstruction tools such
as QuasiRecomb [4], BIOA:VirA [30], QuRe [9] and PredictHaplo [50]. In the current
work we considered only ShoRAH and ViSpA. We applied experiments on IBV 454 shot-
gun reads, collected from commercial poultry farms. For method validation we use IBV
sanger clones as ground truth.
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2.2.2 Methods for viral quasispecies reconstruction
The proposed reconstruction flows consist of the following stages (see Figure 2.19):
1. Read error correction. This step is necessary since the reads produced by 454 Life
Sciences system are prone to errors and it is important to distinguish reading errors
from rare viral variants. As mentioned before, 454 Life Sciences can erroneously
sequence one base pair per 1000 base pair . The error rate is strongly related to the
presence and size of homopolymers [51], i.e. genome regions, consisting of consec-
utive repetition of a single base (for example, TTTTTT).
We use KEC, SAET and ShoRAH programs to do error correction prior to assem-
bly. These error correction algorithms involve clustering of reads. While ShoRAH
clusters the reads in Bayesian fashion using the Dirichlet process mixture [52], and
KEC clusters reads based on kmers [53], SAET uses reads quality scores for error
correction.
2. Read alignment. In this step, we use independent alignment program to map reads
against a reference viral sequence[54], this aligner can be easily replaced with an-
other one.
3. Reconstruction of viral quasispecies. In this step, we use two assembly programs
ViSpA [8] and ShoRAH [7] to reconstruct variants from aligned reads and estimate
their relative frequencies.
ViSpA [8] executes the following steps and outputs the quasispecies spectrum (i.e.
variant sequences and their relative frequencies):
– Preprocess aligned reads. ViSpA uses placeholders I and D for aligned reads con-
taining insertions and deletions, in this process it do a simplistic error correction.
Deletions supported by a single read are replaced either with the allele present in
all the other reads in the same position if they are the same, or with N (unknown
base pair), and removes insertions supported by a single read.
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Figure 2.19 Evaluated reconstruction flows. The flows consists of 3 steps: (1) Read error
correction (2) Read alignment and (3) Reconstruction of viral quasispecies.
– Construct the read graph. In the read graph each vertex corresponds to a read and
each directed edge connects two overlapping reads. ViSpA differentiates between
two types of reads, super-read and sub-read which is a substring of the super-read.
The read graph consists only of super-reads.
– Assemble candidate quasispecies sequences. Each candidate variant corresponds
to a path in the read graph. ViSpA uses what is so called max-bandwidth paths for
assembly.
– Estimate frequency of haplotype sequences. In this step, ViSpA uses Expectation
Maximaization algorithm to estimate the frequency of each reconstructed sequence
using both super-reads and sub-reads.
ShoRAH [7] executes the following steps and outputs the quasispecies spectrum:
– Align reads. The first step for ShoRAH is producing a Multiple Sequence Align-
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ment (MSA) of reads. We used the version 0.5 of the ShoRAH. That version had its
own aligner which was used in the study . It aligns all reads to the reference and
from the set of pairwise alignments it builds a MSA.
– Correct Reads from genotyping errors (Local Haplotype Reconstruction). While
ViSpA uses independent error correction programs, ShoRAH uses its own error cor-
rection method. Sequencing errors are corrected by a Bayesian inference algorithm
which estimates the quality of the reconstruction, although only the maximum like-
lihood estimate is passed on to subsequent steps. ShoRAH implements a specific
probabilistic clustering method based on the Dirichlet process mixture for correct-
ing technical errors in deep sequencing reads and for highlighting the biological
variation in a genetically heterogeneous sample.
– Reconstruct global haplotype. This step is similar to assembly of candidate quasis-
pecies sequences in ViSpA.
– Estimate frequency. In this step, ShoRAH estimates the frequency of each candidate
sequence.
We varied different parameter values. The following tuning parameters are used for
ViSpA quasispecies reconstruction:
– n : number of mismatches between super-reads and sub-reads
– m : number of mismatches in the overlap between two super-reads
– t : mutation rate
For ShoRAH we used the default parameters for quasispecies reconstruction.
2.2.3 Results
Data Sets
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Figure 2.20 Read coverage. Number of reads covered every position in S1 gene.
Read samples were collected from IBV infected chickens, and quasispecies variants
were sequenced using life sciences 454 shotgun sequencing, followed by Sanger sequenc-
ing of individual variants. Reads coverage profile is represented on Figure 2.20. The
initial number of reads was 21,040. After SAET error correction the number of reads
did not change. It decreased to 19,439 after ShoRAH correction and to 17,122 after KEC
correction. Ten Sanger clones (true variants) were used for validation. These clones are
considered as the golden standards or the ground truth for parameter calibration and
comparison between different methods (see Figure 2.21).
Tuning, comparison and validation of methods for quasispecies reconstruction
We measured the pairwise edit distance for the 10 Sanger clones as follow. We ran
pairwise alignment for the Sanger clones using ClustalW, then cut the sticking out ends,
and computed the pairwise edit distance (Levenshtein Distance) for all clones in the over-
lapped region (see Table 2.1).
To validate the reconstruction of the quasispecies using different methods, we com-
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Figure 2.21 Schematic representation of calibration, validation experiments based on
Sanger clones
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Table 2.1 Pairwise edit distance between the 10 Sanger clones. The suffix number of the
clone id is the clone frequency, e.g 42E9_A08_20 means that the frequency of the clone
42E9_A08 is 20%
Sanger clones 42
E9
_A
08
_2
0
42
V
1H
7_
C
02
_2
0
42
E3
_C
07
_1
5
42
A
6_
F0
4_
15
42
E1
0_
B
08
_1
0
42
H
1_
E1
1_
10
42
V
1B
10
_B
04
_0
4
42
V
1H
3_
G
01
_0
4
42
H
5_
A
12
_0
1
42
V
1C
6_
B
08
_0
1
42E9_A08_20 0 0 1 1 1 1 3 3 2 3
42V1H7_C02_20 0 1 1 1 1 3 3 2 3
42E3_C07_15 0 2 2 2 4 4 3 4
42A6_F04_15 0 0 2 2 2 3 2
42E10_B08_10 0 2 2 2 3 2
42H1_E11_10 0 3 2 1 2
42V1B10_B04_04 0 2 4 3
42V1H3_G01_04 0 3 2
42H5_A12_01 0 3
42V1C6_B08_01 0
puted the pairwise distances between Sanger clones and reconstructed variants. We mea-
sured the distances as follows. We computed pairwise alignment between Sanger clones
and reconstructed variants using ClustalW, then cut sticking out ends, and got over-
lapped region between each clone and each variant, the reason behind that, was to avoid
calculating edit distance for uncovered fragments (all overlapped regions happened to be
more than 500 bp long, which is close to Sanger clones average lenght (=550 base pairs)).
As a result of the previous step, we got several groups of identical overlapped re-
gions of reconstructed variants and collapsed them, and summed up their frequencies
(the suffix of the variant sequences ID’s represent the collapsed variant abundance, for
example, the frequency of the variant 42E9_A08_40 is 40%).
Identical Sanger clone fragments were also collapsed (for example, the 2 most fre-
quent clones 42E9_A08_20 and 42V1H7_C02_20 are collapsed to 42E9_A08_40). Then we
computed edit distance for every overlapped region.
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Table 2.2 Edit distance between collapsed Sanger clones and ViSpA reconstructed vari-
ants using parameters 1,2,5 (number of mismatches between sub-reads and super-reads,
number of mismatches between two overlapped reads and mutation rate respectively),
threshold=0.005 on KEC corrected reads
Sanger clones
Frequencies of reconstructed variants 42
E9
_A
08
_4
0
42
A
6_
F0
4_
25
42
E3
_C
07
_1
5
42
H
1_
E1
1_
10
42
V
1B
10
_B
04
_0
4
42
V
1H
3_
G
01
_0
4
42
H
5_
A
12
_0
1
42
V
1C
6_
B
08
_0
1
0.6647 0 1 1 1 3 3 2 3
0.1212 1 0 2 2 2 2 3 2
0.0399 1 2 0 2 4 4 3 4
0.1054 2 3 3 3 5 5 4 5
0.0461 2 1 3 3 3 3 4 3
0.0228 1 2 2 2 4 4 3 4
Table 2.2 shows edit distance values between distinct Sanger clones and recon-
structed variants for one of the dominating methods using ViSpA where the number of
mismatches between super-reads and sub-reads (n) is 1, the number of mismatches in the
overlapping region between two reads (m) is 2 and the mutation rate (t) is 5. We con-
sidered only reconstructed variants with frequencies more than 0.005 (threshold=0.005).
Reads are corrected using KEC program.
As we see from the Table 2.2, the method correctly reconstructed three the most fre-
quent variants. Thus in the overlapped region, there was edit distance 0 between the most
frequent Sanger clone with id 42E9_A08_40 and frequency 0.40 and the reconstructed
variant with the frequency 0.6647. As well as 42A6_F04_25 clone was identical to the
variant with frequency 0.1212 and 42E3_C07_15 clone was identical to the variant with
frequency 0.0399. The method a little overestimated the highest frequency - obtained
0.6647 for the most popular variant instead of true 0.40. On the other hand, it underesti-
mated the second and the third popular variants - obtained frequencies 0.1212 instead of
0.25 and 0.0399 instead of 0.15. On the whole, the validation with distinct Sanger clones
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Figure 2.22 Phylogenetic tree over collapsed Sanger clones and collapsed reconstructed
variants inferred from the method with parameters 1_2_5 on KEC corrected reads using
ViSpA.
show that existing reconstruction methods can give adequate representation of IBV vari-
ant population.
To compare how well the reconstructed variant sequences of the previous method
were compared to Sanger clones, we reconstructed the phylogenetic tree, see Figure 2.22
(it shows only the frequecies for the reconstructed variants, while a Sanger clone starts
with the number 42). As we can see from the phylogenetic tree, the reconstructed variants
by ViSpA are close to Sanger clones.
To compare between different methods (with different parameter settings), we use
the following two measures:
– average distance to clones ADC=
∑
i d(ci) · f(ci)
– average prediction error APE=
∑
j d(qj) · f(qj),
where c1, ..., c10 are Sanger clones, q1, ..., qj are reconstructed variants, f(ci) and f(qj) are
frequencies of ith clone and jth variant and d(ci) and d(qj) are edit distance from ith
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Table 2.3 Edit distance between collapsed Sanger clones and ViSpA reconstructed variants
using parameters 2, 2, 10 (the number of mismatches between sub-reads and super-reads,
the number of mismatches between two overlapped reads, and mutation rate respec-
tively), threshold=0.005 on KEC corrected reads, where 85% of reconstructed variants
have perfect match with 65% of the Sanger clones.
Sanger clones
Frequencies of reconstructed variants 42
E9
_A
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_4
0
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A
6_
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4_
25
42
E3
_C
07
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1_
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_0
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V
1C
6_
B
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1
0.6703 0 1 1 1 3 3 2 3
0.1845 1 0 2 2 2 2 3 2
0.0054 4 3 5 5 5 5 6 5
clone to the closest reconstructed variant and edit distance from jth reconstructed variant
to the closest clone.
ADC and APE are analogous to sensitivity and ppv respectively. The difference is
that ADC and APE indicate better quality whenever they are closer to 0, while sensitivity
and ppv indicate better quality when they are closer to 1.
In addition to the previous method. We ran many other experiments using different
methods (see Tables 2.3 - 2.5 and Figures 2.23 - 2.25) and calculated the values of Average
Distance to Clones (ADC) and Average Prediction Error (APE) for each method as shown
in Table 2.6 and Table 2.7 respectively (ViSpA 1_2_5 means that the variants are recon-
structed by ViSpA using parameter values n=1, m=2, t=5). The Table 2.5 shows that the
method is able to recall or reconstruct 12.7% of the variants with 0 edit distance with the
most frequent Sanger clones (40%), 6.6% of the variants with 0 edit distance with 25% fre-
quent Sanger clones, 3.8% of the variants with 0 edit distance with 15% frequent Sanger
clones, therefore the used method is able to reconstruct or recall 23% (0.127+0.066+0.038)
of the variants with 0 edit distance with 80% (0.40+0.25+0.15) of Sanger clones with rela-
tively small precision since it reconstructs more false negatives.
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Table 2.4 Edit distance between collapsed Sanger clones and ViSpA reconstructed variants
using parameters 1, 2, 0 (the number of mismatches between sub-reads and super-reads,
the number of mismatches between two overlapped reads, and mutation rate respec-
tively), threshold=0.005 on SAET corrected reads.
Sanger clones
Frequencies of reconstructed variants 42
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0.1448 0 1 1 1 3 3 2 3
0.0714 1 0 2 2 2 2 3 2
0.0067 1 2 0 2 4 4 3 4
0.1923 1 2 2 2 4 4 1 4
0.0469 2 3 3 3 5 5 4 5
0.0061 4 5 5 5 7 7 6 7
Figure 2.23 Phylogenetic tree over collapsed Sanger clones and collapsed reconstructed
variants inferred from one of the dominating methods with parameters 2_2_10 on KEC
corrected reads using ViSpA.
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Table 2.5 Edit distance between collapsed Sanger clones and ShoRAH reconstructed vari-
ants using default parameters, threshold=0.005 on Uncorrected reads.
Sanger clones
Estimated variant frequencies 42
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0.1277 0 1 1 1 3 3 2 3
0.0663 1 0 2 2 2 2 3 2
0.0386 1 2 0 2 4 4 3 4
0.0535 4 5 5 5 7 7 6 7
0.0526 2 3 3 3 5 5 4 5
0.0434 8 9 9 9 11 11 10 11
0.0289 3 4 4 4 6 6 5 6
0.0268 9 10 10 10 12 12 11 12
0.0263 5 6 6 6 8 8 7 8
0.0259 4 5 5 5 7 7 6 7
0.0243 3 2 4 4 4 4 5 4
0.0191 6 7 5 7 9 9 8 9
0.0189 5 6 4 6 8 8 7 8
0.0172 3 4 4 4 6 6 5 6
0.01718 1 2 2 2 4 4 3 4
0.0167 9 10 8 10 12 12 11 12
0.0159 2 3 1 3 5 5 4 5
0.0156 3 2 4 4 4 4 5 4
0.0127 10 9 11 11 11 11 12 11
0.0110 4 5 5 5 7 7 6 7
0.0097 1 2 2 2 4 4 3 4
0.0089 12 13 13 13 15 15 14 15
0.0088 1 2 2 2 4 4 3 4
0.0084 5 4 6 6 6 6 7 6
42
Figure 2.24 Phylogenetic tree over collapsed Sanger clones and collapsed reconstructed
variants inferred from one of the dominating methods with parameters 1_2_0 on SAET
corrected reads using ViSpA.
43
Figure 2.25 Phylogenetic tree over collapsed Sanger clones and collapsed reconstructed
variants inferred from one of the methods with default parameters on Uncorrected reads
using ShoRAH (close to the dominating methods).
Table 2.6 Average distance to clones (ADC) for the reconstructed variants using different
methods
Error Correction Method
Uncorrected KEC SAET
ViSpA 1_2_0 0.45 0.79 0.29
ViSpA 1_2_5 0.3 0.3 0.45
ViSpA 1_2_10 0.45 0.45 0.3
ViSpA 2_2_0 0.45 0.79 0.3
ViSpA 2_2_5 0.45 0.3 0.3
ViSpA 2_2_10 0.3 0.45 0.3
ShoRAH 0.3 0.3 0.3
We say that the method A dominates the method B if both ADC and APE values of
A are at most the corresponding ADC and APE values of B. The Figure 2.26 (a pictorial
diagram of Tables 2.6 and 2.7) shows that methods V125KEC (V: ViSpA assembler, 1:n,
2:m, 5:t, KEC:correction method), V2210KEC, and V120SAET dominate all other methods,
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Figure 2.26 Evaluation diagram for average prediction error (APE) and average distance
to clones (ADC) values for different methods. Each point corresponds to a method and
the dominant solutions correspond to red points.
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Table 2.7 Average prediction error (APE) for the reconstructed variants using different
methods
Error Correction Method
Uncorrected KEC SAET
ViSpA 1_2_0 0.2 0.16 0.66
ViSpA 1_2_5 0.63 0.28 0.58
ViSpA 1_2_10 0.53 0.18 0.45
ViSpA 2_2_0 1.35 0.26 3.12
ViSpA 2_2_5 0.2 0.29 0.31
ViSpA 2_2_10 0.41 0.02 0.41
ShoRAH 2.84 2.89 2.45
i.e. have the best values in terms of ADC and APE. Our results suggest that using different
methods with different parameter calibration and parameter settings can improve the
solution and its predictive power for the quasispecies inference problem in terms of recall
and precision.
2.2.4 Conclusion
In this work, we have proposed evaluated reconstruction flows consisting of three
stages, read error correction, read alignment, and quasispecies reconstruction. We vary
different methods with different parameter values for accurate reconstruction of viral
quasispecies sequences and estimate their frequencies from HTS data. We have proposed
novel validation methods to validate our reconstructed quasispecies compared to Sanger
clones as ground truth. Our experimental results show that varying different methods
with different parameter calibration and parameter settings can improve the solution and
predictive power of quasispecies inference problem in terms of recall and precision.
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PART 3
PHAGE DISPLAY DATA PROCESSING FOR IMMUNE RESPONSE ANALYSIS
3.1 Introduction
The role of the immune system is to protect an organism against disease by respond-
ing to antigens. Antigens are substances (usually proteins) on the surface of cells, viruses,
fungi, or bacteria causing disease. The immune system uses antibodies to identify anti-
gens and neutralize disease. Serum antibodies are valuable source of information on the
health state of an organism [11].
Since an antibody recognizes not the whole antigen but 4-7 critical amino acids
within the epitope, the whole proteome can be represented by RPPDL which is commer-
cially available from New England Biolabs (NEB). The RPPDL contains almost all pos-
sible 7-mer peptide sequences that can be screened against, for example, blood serum,
and binding peptides will represent antibody response. The RPPDL are widely used for
identification of the epitope specificity of monoclonal antibodies. The obstacle for us-
ing RPPDL as diagnostic tools was the necessity to sequence large number of individual
phage DNA for identification of epitopes recognized by antibodies. The NGS technology
makes possible to identify all the epitopes recognized by all antibodies contained in the
human serum using one run of the sequencing machine.
Recently, RPPDL were applied to studies of antibody response to different diseases.
In [55] the authors studied serum samples from patients with severe peanut allergy using
phage display. The phage were selected based on their interaction with patient serum
and characterized by highthroughput sequencing. The epitopes of a prominent peanut
allergen, Ara h 1, in sera from patients were identified.
We used RPPDL to study antibody response to breast cancer and Lyme disease. The
approach for the representation of serum antibody repertoire by RPPDL is outlined in the
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flowchart in Figure 3.1. Ph.D-7 phage displayed library of 7-mer random peptides was
mixed with the serum and incubated overnight. Phage bound to antibodies was isolated
using protein-G beads and eluted from the beads using low pH buffer. The eluted phage
was amplified by propagation in E.coli and the amplified library was incubated with the
same serum. The phage bound to antibodies was isolated using protein-G beads and the
phage DNA was PCR amplified with the primers flanking the peptide coding insert. The
library of peptide coding inserts was sequenced by NGS and the DNA sequences were
translated into the peptide sequences. Obtained peptides represent a mimotope profile
of a serum sample - mimic of all epitopes recognized by all antibodies contained in the
serum. Mimotope profiles of different samples can be studied and compared with each
other.
Figure 3.1 A scheme for generating mimotope profiles of serum antibody repertoire.
Generating peptide profiles. Twenty µl of serum and 10 µl of the enriched library
were diluted in 200 µl of the Tris Buffered Saline (TBST) buffer containing 0.1% Tween
20 and 1% BSA and incubated overnight at room temperature. The phages bound to an-
tibodies were isolated using low pH buffer as described above for the enrichment of the
library and the phage DNA was isolated using phenol-chloroform extraction and ethanol
precipitation. The 21 nt long DNA fragments coding for random peptides were PCR-
amplified using primers containing a sequence for annealing to the Illumina flow cell,
the sequence complementary to the Illumina sequencing primer and the 4 nt barcode
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sequence for multiplexing. The PCR-amplified DNA library was purified on agarose ge-
multiplexed and sequenced by 50 cycle HiSeq 2500 platform.
The sequences were de-multiplexed to determine its source sample. The 21- base
nucleotides were extracted between base position 29 and 49 and translated to 7-amino-
acid peptide using the first frame. Any peptide containing stop codon was discarded.
3.2 Methods for finding mimotope motifs
The profiles generated by NGS following several iterative round of affinity selection
and amplification in bacteria can consist of millions of peptide sequences. A significant
fraction of these sequences is not related to the repertoires of antibody specificities, but
produced by nonspecific binding and preferential amplification in bacteria. The presence
of high amounts of these unspecific, quickly growing ”parasitic” sequences can compli-
cate the analysis of serum antibody specificities. The affinity selected sequences can be
clustered into groups of similar sequences with shared consensus motifs, while the para-
sitic sequences are usually represented by single copies.
There are two main approaches for finding mimotope motifs. First one is based on
clustering, second is based on BLAST alignment. Further in this chapter, we describe two
proposed methods for motif finding based on CAST clustering and based on k-means
clustering and apply these methods to real data. We also apply BLAST alignment method
to Lyme disease NGS data to find epitopes and analyze immune response during the
different stages of the disease disease.
3.3 Mimotope motif finding based on CAST clustering
We define motif as a group of peptides having common sequence pattern. If we con-
sider a motif as a cluster formed by peptides with the center represented by a consensus
sequence then construction of a motif corresponds to a difficult clustering problem with
many closely located centers. The radius of a cluster may exceed the distance from one
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cluster to another one. To solve the problem we modified CAST clustering algorithm
(Clustering Affinity Search Technique) [22]. We did not know in advance how many
motifs should be found in each sample. Other words, we did not know the number of
clusters. For this reason we used CAST. It does not assume a given number of clusters and
an initial spatial structure of them, but determines cluster number and structure based on
the data.
The input of CAST consists of a similarity matrix to store the distances of all of the
peptides and an similarity threshold. We defined the similarity of two sequences of
equal length as the number of positions where the corresponding symbols are equal. We
also consider the shifts of sequences relative to each other where it is necessary. For exam-
ple, if we have two peptide sequences MLPHWAS and LPHWASK we need to shift them
on one position relative to each other to get common overlap LPHWAS. In this example
the similarity will be equal 6. Since the minimal length of a peptide sequence that can
mimic the epitope recognized by antibody is usually in the range from 4 to 7 amino acids,
we assigned similarity threshold equal 4. So any two peptides in a motif should have ap-
proximately 4 common amino acids (diameter of a motif). As well as no more than three
shifts between peptides to the right or left sides were allowed.
The Algorithm 1 describes the CAST-based motif identification method (CMIM). On
every iteration of the algorithm two peptides with the highest similarity were chosen as
the initial center of a cluster. Next the process of adding and removing of peptides from
the cluster was performed while the similarity between every pair of petides in a final
set were not less than the threshold. During that step initially assigned central peptides
could be removed. A measure of similarity between a peptide and all other peptides in a
cluster was called affinity. Obtained cluster was saved removing its peptides from fur-
ther consideration as initial centers. Then the procedure was repeated to find remaining
motifs. Unlike CAST our algorithm allows intersection between clusters. As result some
consensus sequences of motifs could be too close to each other. So the obtained clusters
were collapsed if they had more than 50% common peptides. The last step was to align all
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Algorithm 1 CAST-based motif identification (CMIM)
Input: Set of peptides P, similarity matrix D, threshold θ
Set of seed peptides S← P
while S 6= ∅ do
Cluster setM← {s1, s2}, s1, s2 - the two most similar peptides in S
Set of petides outside the cluster R← P \M
affinity(p)← D(p, s1) +D(p, s2), for all p ∈ P
while there is any change inM do
while ∃r ∈ R s.t. affinity(r)/|M| ≥ θ do
M←M ∪ {r ′}, r ′ ∈ R - peptide with the highest affinity
affinity(p) ← affinity(p) + D(p, r ′), for all p ∈ P - update affinity of all
peptides
end while
while ∃m ∈M s.t. affinity(m)/(|M| − 1) < θ do
M← C \ {m ′}, m ′ ∈M - peptide with the lowest affinity
affinity(p) ← affinity(p) − D(p,m ′), for all p ∈ P - update affinity of all
peptides
end while
end while
S← S \M
AddM to set of clusters M
end while
for any pair {M ′,M ′′} ∈M do
if (|M ′ ∩M ′′|/|M ′| > 0.5) or (|M ′ ∩M ′′|/|M ′′| > 0.5) then
CollapseM ′ andM ′′
end if
end for
for anyM ∈M do
align peptides inM
calculate entropy in every position i of alignedM
find consensus K for 7-mer window with themin entropy
end for
Output: Set of motifs M, represented by clustersMi and consensus sequences Ki
peptides in the cluster and compute entropy in every position. Seven positions with the
smallest cumulative entropy (the most conserved part) were chosen, and the consensus
amino acid sequence was found. The output of the algorithm was a set of finding motifs
in a serum sample, each represented by a cluster and its consensus 7-mer sequence. To
compute consensus sequence for a motif we aligned peptide sequences in its cluster and
calculated entropy in every position of the cluster. Then we chose seven positions win-
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dow with the minimum total entropy and identified consensus as the order of the most
frequent amino acids found at each chosen position.
3.4 Application of CAST-based motif finding to breast cancer NGS data
3.4.1 Motivation
Cancer cells starts out as normal body cells, but they begin to grow out of control be-
cause of an abnormal gene expression. The immune system plays a major role in limiting
the development of these abnormalities. There are multiple lines of evidence that the im-
mune system elicits a detectable humoral immune response to changes in antigen profiles
caused by growing cancer cells [56, 57, 58, 59, 60]. Circulating autoantibodies produced
by the patient’s own immune system after exposure to cancer proteins are promising
biomarkers for the early detection of cancer. An advantage of autoantibodies in cancer
detection is their production in large quantities, despite the presence of a relatively small
amount of the corresponding antigen. It has been demonstrated, that panels of antibody
reactivities can be used for detecting cancer with high sensitivity and specificity [61].
The current methods of analysis of antitumor humoral immune response, such as
SEREX, SERPA, antigen microarrays, or ELISA are designed to detect high- affinity/high-
titer IgG or IgM antibodies. However, the immune system can react to alterations in
local antigenic compositions caused by growing tumors by pro- ducing a variety of low-
affinity/low-titer antibodies. There is a need to develop more sensitive method. Recently
the authors tested whether immunosignatures correspond to clinical classifications of dis-
ease using samples from people with brain tumors. The immunosignaturing platform
distinguished not only brain cancer from controls, but also pathologically important fea-
tures about the tumor including type and grade [62]. These results clearly demonstrate
that random peptide arrays can be applied to profiling serum antibody repertoires for
detection of cancer. The important advantage of using peptide arrays instead of antigen
arrays is that peptides can mimic not only the protein epitopes but also the carbohydrate
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epitopes that represent an essential part of the repertoire of cancer-associated autoanti-
bodies.
3.4.2 Library enrichment
Studying immune response to breast cancer we decided to decrease the number of
peptides in profiles generated by NGS without losing cancer-specific sequences.For gen-
eration of profiles we used the phage library enriched by panning on the pool of cancer
sera. The approach for generating mimotope profiles of serum antibody repertoire is out-
lined in the flowchart in Figure 3.2. We extended a standard approach from Figure 3.1
by enriching the library by cancer specific peptides. First, the initial RPPDL was mixed
with pooled cancer serum. After three rounds of incubation, elution and amplification a
new library was obtained enriched by peptides specific for cancer. The second step was
directly generating of mimotope profiles and NGS using the enriched library instead of
the initial random library. Pooled serum from eight stage 0 breast cancer patients were
used for enrichment of the library.
Generating peptide profiles with enrichment. The enrichment was performed as
follows. Twenty µl of pooled serum and 10 µl of the Ph.D.7 random peptide library (NEB)
were diluted in 200 µl of the Tris Buffered Saline (TBST) buffer containing 0.1% Tween 20
and 1% BSA and incubated overnight at room temperature. The phages bound to an-
tibodies were isolated by adding 20 µl of protein G agarose beads (Santa Cruz) to the
phage antibody mixture and incubating for 1 hour. To eliminate the unbound phage the
mixture with beads was transferred to the well of 96-well MultiScreen-Mesh Filter plate
(Millipore) containing 20 µm pore size nylon mesh at the bottom. The unbound phage
was removed by applying vacuum to the outside of the nylon mesh using micropipette
tip. The beads were washed 4 times by adding to the well 100 µl of TBST buffer and
removing the liquid by applying vacuum to the outside of the nylon mesh using mi-
cropipette tip. The phage bound to the antibodies was eluted by adding to the beads of
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Figure 3.2 A scheme for generating mimotope profiles of serum antibody repertoire. The
first step of the experiment is library enrichment, the second step is directly generating of
mimotope profiles and NGS.
100 µl of 100 mM Tris-glycine buffer pH 2.2 followed by neutralization using 20 µl 1 M
Tris buffer pH 9.1. The eluted phages were amplified in bacteria by infecting 3 ml of an
early log-phase culture . The amplified phages were isolated by precipitating phage with
1/6 volume of 20% PEG, 05.M NaCl precipitation buffer. The cycle of incubation-bound
phage isolation-amplification was repeated two more times and the isolated after the 3rd
amplification library was used for analyzing antibody repertoires.
3.4.3 Results
Data set. We analyzed the profiles generated for the 15 serum samples of the stage 0
and 1 breast cancer patients and for the 15 serum samples of the healthy donors. For each
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serum sample the experiment was performed separately using the same enriched library
on all samples. In average, for the experimental condition selected, the total number of
distinct peptide sequences generated in one sample was 18,450, and standard deviation
σwas 6205. The average count value (expression) of a sample was 407,335(σ = 252,393).
After applying CMIM separately to every sample, we obtained in average 3,000(1,073)
motifs per a control sample and 3,490(1,315) motifs per a case sample. The average size of
a motif in a case was 7.1(1.8) peptides, in a control it was 6.8(1.3) peptides. Every sample
contained significant amount of large motifs. Thus, the average number of motifs consist-
ing of 20 and more peptides was 154(71) and 131(53) for cases and controls respectively.
Motif validation. To validate found motifs we generated pseudo mimotope pro-
files using two strategies. The first strategy was random permutation of amino acids in
a sample peptides. As result, we received 30 samples consisting of random 7-mer pep-
tides. We ran our motif search method on the samples and obtained about 6,639(1,967)
motifs with the average size 4.2(0.7). Although, the largest motif among all samples con-
tained only 17 peptides. More than 95% of motifs in all samples had size no more than 4
peptides.The obtained motifs were significantly different from those found in real serum
samples. This result proves the amino-acid order is meaningful in mimotope motifs found
by CMIM.
The second strategy was random selection of peptides from existing samples and
generating random samples. We collapse all original serum samples together assigning
count value to each peptide. The more abundant and popular a peptide was among sam-
ples the more probable it would be selected to a new random sample. We generated 30
samples with 20K peptides each. We also applied motif search method to the random
samples. In average we obtained 3,890(34) motifs with the size of 5.71(0.04) peptides. To
compare the group of random samples with the group of real serum samples we applied
Kruskal-Wallis test [63]. This non-parametric method determines whether samples orig-
inate from the same distribution. The result p-value was 7.5 ∗ 10−5 rejecting the null hy-
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pothesis that the population medians of both groups were equal. Thus, the single sample
motifs are significantly different from motifs in peptides drawn from multiple samples.
Cancer-specific motifs. The cancer-specific motifs were defined as motifs signif-
icantly prevalent in cases. We compared motifs based on their consensus 7-mers. If
two samples shared any consensus sequence, we considered they shared the correspond-
ing motif. A motif was associated with cancer if probability of its appearance in cases
against controls by chance was less than 0.05. We calculated the probability of all possi-
ble combinations of 15 cases and 15 controls and chose the most discriminating. As re-
sult, we received the following case-control significant combinations with probability less
0.05: 4-0 (a motif should appeared in 4 cases and 0 controls), 5-0, 6-0,...,15-0,6-1,...,15-1,8-
2,...15-2,9-3,...15-3,10-4,...,15-4,11-5,...15-5,12-6,...,15-6,13-7,...,15-7,14-8,...,15-8,...,15-11. We
also found the combinations with probability less than 0.04, 0.03, 0.02 and 0.01. There
were 67 cancer specific motifs with probability of case-control appearance less than 0.05,
27 motifs with probability less than 0.04, 24 motifs with probability less than 0.03, 10 and
4 motifs with probability less than 0.02 and 0.01 respectively.
To validate obtained motifs we applied permutation test. We tested, at 5% signifi-
cance level, whether the number of observed motifs can be obtained by chance. The test
proceeded as follows. Cases and controls were randomly swapped, so some cases were
considered as controls while controls were considered as cases. Totally 10K random per-
mutations were performed. For every permutation the number of motifs with significant
case-control appearance was count. The one-sided p-value of the test was calculated as
the proportion of permutations where the number of significant motifs was greater or
equal to observed number (see Table 3.1). As far as all p-values were greater than 0.05
we can not reject the hypothesis that the number of observed motifs could be obtained by
chance.
The number of expected and observed motifs as well as False Discovery Rate (FDR)
[64] adjustment are also shown in Table 3.1. Notice that the number of observed motifs
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Table 3.1 Statistics for case-specific motifs. The number of observed motifs with expected
number, FDR and p-value of the permutation test.
probability observed expected FDR p-value of the permutation test
<0.05 67 51.9 0.77 0.15
<0.04 27 20.5 0.76 0.21
<0.03 24 16.6 0.69 0.15
<0.02 10 8.1 0.81 0.32
<0.01 4 4.2 1.06 0.52
with probability of case-control appearance less than 0.01 equals to 4 which is less than
expected number 4.2. That gives FDR greater than 1. Despite the fact that no motif is
statistically significant, we can see that their number is still larger than expected.
3.4.4 Conclusion
In current work we identified cancer-specific motifs by analyzing peptide profiles
of serum samples from cancer patients and from healthy donors. These profiles were
generated using a phage DNA sequencing following single selection without amplifica-
tion on the serum samples with the library enriched by the cycles of affinity selection-
amplification using a pool of serum samples from additional cancer patients.
A novel motif identification method based on CAST clustering (CMIM) was pro-
posed. We found that for any real serum sample the number of peptides per a motif is
significantly greater comparing with pseudo epitope repertoire consisting of a randomly
permuted peptides. Also the single sample motifs are shown to be significantly different
from motifs in peptides drawn from multiple samples.
Running on case-control data CMIM identified cancer-specific motifs. Although no
motif is statistically significant after permutation test, the number of found motifs is larger
than expected and may therefore contain useful cancer markers.
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3.5 Mimotope motif finding based on k-means clustering
Another clustering method is k-means. It requires less computing power than CAST
but the number of clusters (motifs among peptides) should be predefined. For this reason,
as an initial step, we propose to build a grid of peptides which pairwise similarity far from
each other, less than some similarity threshold. The size of the grid is input parameter for
k-means. All clusters are built around grid peptides (see Algorithm 2).
Algorithm 2 K-means-based motif identification
Input: Set of peptides P, similarity matrix D, threshold θ
1: Select a set of seeds S from the set of peptides P = {pi, i = 0, . . . |P|.}
S← {p0}
for i = 1, . . . , |P| do if for each s ∈ S similarity of pi and s is less than Tseeds, then
S← S ∪ pi
2: For each seed peptide si, initialize cluster C = si and compute the profile M(C)
associated with C.
repeat
3: For each peptide pi ∈ P find the closest motifM and assign pi toM’s cluster.
4: For each cluster C do remove all peptides, add all peptides assigned to C, and
update profileM(C).
until no changes in clusters
3.6 Application of mimotope motif finding based on BLAST alignment to Lyme dis-
ease
3.6.1 Motivation
Lyme disease (LD), the most prevalent tick-borne illness in North America and Eu-
rope, is caused by spirochetes in the genus Borrelia. Borrelia burgdorferi, the principal
human pathogen in the United States, is responsible for approximately 300,000 LD cases
per year [65]. LD is problematic because early diagnosis is easily missed due to flu-like
symptoms, which only transiently appear in humans during an early stage of disease. No
preventable or therapeutic vaccine for humans is currently available.
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The long-term survival of B. burgdorferi spirochetes in the mammalian host is
achieved though the B. burgdorferi antigenic variation system [66]. This elaborate sys-
tem, first identified on a 28-kb linear plasmid (lp28-1) of the B. burgdorferi B31 strain,
is composed of a vlsE expression site and 15 noncoding silent cassettes. As a result of
segmental conversion from the cassettes into the vlsE gene, variants of the VlsE (variable
major protein-like sequence expressed) surface lipoprotein are generated [67, 68]. The
vls-mediated variation of VlsE is absolutely required for persistence in mice as murine
antibody clears the vls-deficient B. burgdorferi clone (∆vlsE strain) or the B. burgdorferi
clone with nonswitchable VlsE (sVlsE, for static VlsE) [69, 70, 71, 72, 73, 74]. Besides VlsE,
however, B. burgdorferi expresses numerous other surface (lipo)proteins that, in contrast
to VlsE, are invariant [75]. Antibody developed to non-VlsE surface antigens can protect
mice from B. burgdorferi infection when variable VlsE is absent [74].
The central hypothesis that we tested was whether the protective efficacy of the anti-
body response to B. burgdorferi non-VlsE surface antigens declines as B. burgdorferi in-
fection progresses in mice. The approach involving RPPDL and NGS was undertaken to
test the hypothesis and to compare specificities of serum antibody developed during the
early and late stages of B. burgdorferi infection. Although RPPDL have been widely used
for mapping epitopes [76, 77, 78], the tool was previously applied for epitope discovery
of B. burgdorferi proteins by only two studies [79, 80]. Specifically, we apply statistical
analysis to detect any significant difference between mimotope profiles of mice at day-
28 and day-70 of infection. To solve the problem of parasitic sequences we performed
additional analysis based on BLAST clustering where considered only peptides mapped
with high similarity to surface lipoproteins of Borrelia burgdorferi that are antigens and
to vlsE protein that is responsible for persistence of the infection in a host.
3.6.2 Generating serum antibody repertoire profiles using RPPDL
The approach for generating mimotope profiles of serum antibody repertoire is out-
lined in the flowchart in Figure 3.1. Twenty microliters of mouse serum and 10 µl of
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the Ph.D.-7 random peptide library were diluted in 200 µl of Tris-buffered saline (TBST)
buffer containing 0.1% Tween 20 and 1% bovine serum albumin (BSA) and then incu-
bated overnight at room temperature. The phages bound to antibodies were isolated
by applying 20 µl of protein G-agarose beads (Santa Cruz Biotechnology, Inc., TX, USA)
to the phage-antibody mixture for 1 h. To eliminate unbound phages, the mixture with
beads was transferred to a 96-well MultiScreen-Mesh filter plate (EMD Millipore, MA,
USA) containing a 20-µm-pore-size nylon mesh on the bottom. Unbound phages were re-
moved by applying a vacuum to the outside of the nylon mesh. The beads were washed
four times with 100 µl of TBST buffer per well. Antibody-bound phages were eluted
with 100 µl of 100 mM Tris-glycine buffer (pH 2.2). Then the buffer was replaced with
20 µl of 1 M Tris buffer (pH 9.1). The eluted phages were amplified by infecting bac-
teria according to the manufacturer’s instructions. Amplified phages were subjected to
two additional rounds of biopanning. Antibody-bound phages were isolated using pro-
tein G-agarose beads. DNA was isolated via phenol-chloroform extraction and ethanol
precipitation. The 21-nucleotide (nt)-long DNA fragments coding random peptides were
then PCR amplified using the following forward and reverse primers, respectively:
5’ - AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCT
TCCGATCT(INDEX)TGGTACCTTTCTATTCTCACTCT - 3’ and
5’ - CAAGCAGAAGAGGGCATACGAGCTCTTCCGATCTAACAG TTTCGGCCGA
ACCTCCACC - 3’.
The INDEX in the sequence of the forward primer indicates a 6-nt barcode, which
allows sequencing multiple libraries using a single line of the Illumina flow cell. For
each mouse serum, a distinct forward primer with unique index sequence was used. The
multiplexed PCR-amplified DNA library was then purified on agarose gel and sequenced
using an Illumina HiSeq 2500 platform.
As a result of sequencing, a total of about 116 million DNA reads were obtained.
Reads were demultiplexed based on the barcodes. Each read contained a unique in-
dex sequence of 6-nt in length and a 21-nt sequence coding a random peptide: 5’-
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(INDEX)GTGGTACCTTTCTATTCTCACTCT(21-nt sequence)G - 3’. Then the 21-nt se-
quences were extracted from each read between positions 30 and 50 and translated to
7-mer peptides in the first frame. Peptides that contained stop codons were not included
in the analysis. The average number of all peptides per serum sample was approximately
1× 107. The number of distinct peptides identified was approximately 1.4× 105 per sam-
ple. The data was then analyzed via the Python programming language.
3.6.3 Method for comparison of mimotope profiles on days 28 and 70 of B.
burgdorferi infection
The strength of association between a peptide and a serum sample was measured as
follows. A peptide, P, was associated with day 28 serum if X(P), the lowest frequency of
P among day 28 serum samples, was higher than Y(P), the highest frequency of P among
day 70 serum samples. The strength of association was then measured by the size of the
gap: X(P) − Y(P). Similarly, a peptide was associated with day 70 serum samples if its
smallest frequency among day 70 serum samples was higher than the highest frequency
among day 28 serum samples. The statistical significance of the difference between the
number of peptides associated with the day 28 serum and the number of peptides asso-
ciated with the day 70 serum was measured using a permutation test. The permutation
test was used because of the comparatively small number of samples (five serum samples
per each time point). For each of 252 possible permutations, the difference between the
numbers of associated peptides was found and compared with the actual difference.
3.6.4 BLAST alignment of peptides to VlsE and other B. burgdorferi proteins
As far as significant fraction of peptide sequences in a profile is noise, the additional
analysis was performed where only peptides mapped to Borrelia’s surface lipoproteins
and vlsE were considered. For each serum sample, all peptides were mapped to VlsE of
B. burgdorferi 297 (297-VlsE) (GenBank accession number AB041949.1) or B31 (B31-VlsE)
(GenBank accession number AAC45733.1) strains using blastp with an identity threshold
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of 4 (i.e., only alignments with at least four exact amino acid matches were taken into
account). For each VlsE position X, a peptide with the amino acid matched to position X
and with K different VlsE matches contributed its frequency divided by K to the coverage
of X. Overall, the coverage of X, C(X), was computed as the sum of contributions of
all peptides matched to X. Similarly, all peptides were mapped to other B. burgdorferi
surface proteins of the two B. burgdorferi strains, decorin-binding proteins A (DbpA),
DbpB, and P35.
3.6.5 Results
The data analyses revealed that only 366 and 14 peptides, respectively, were associ-
ated with the day 28 and day 70 serum samples. The difference between the two numbers
was statistically significant, with a p-value estimated via a permutation test being below
0.25%. However, when a multiple testing correction was applied, no significant differ-
ence in antibody repertoires was identified between the two time points of B. burgdorferi
infection.
In order to compare anti-VlsE antibody responses between days 28 and 70 p.i., for
each samples all peptides were mapped to the strain 297 VlsE (297-VlsE) or B31-VlsE via
blastp analysis (Figure 3.3). The epitope mapping against the linear B31-VlsE structure
showed no significant difference between the reactivities of day 28 and day 70 antibodies.
Predicted cross-reactivity of anti-297-VlsE antibody to linear B31-VlsE is partially consis-
tent with the anti-VlsE antibody reactivity of LD patients [81]. Microarray-based epitope
mapping demonstrated that IgG antibody of patients with chronic Lyme disease were
mainly reactive to six peptides of B31-VlsE. The immunodominant epitopes were located
within two invariable domains (VlsE residues 21 to 31, 61, 96, and 336 and 343) and one
variable domain (VlsE residues 196 and 271 to 291). Consistently, reactivity of anti-297
antibody was predicted to invariant region 6 (IR6). IR6 has been shown to be highly im-
munogenic in humans, monkeys, and mice [82, 83, 84]. In addition to IR6, C3H mice may
also develop a strong antibody response to IR2 and IR4 [84]. However, reactivity to these
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Figure 3.3 Epitope mapping of VlsE. Primary structure of B31-VlsE illustrating two direct
repeats (DR1 and DR2; green) that demarcate one variable domain and two invariable do-
mains. Shown are also six invariable (IR; gray) and variable (VR; pink) regions [1] (A).
Heat maps were generated from predicted reactivity of anti-297 antibody to the primary
structure of B31-VlsE (B) and 297-VlsE (C). Anti-297 sera were harvested from B. burgdor-
feri persistently infected C3H mice at days 28 and 70 postinfection (five animals per time
point). The linear B31-VlsE structure is scaled to the B31-VlsE heat map.
conserved regions was not pronounced in the present study (Figure 3.3).
Interestingly, IR2 and IR4 are not antigenic in humans and monkeys [84]. The anal-
ysis also predicted strong reactivity of anti-297 antibody to the C-terminal invariable do-
main (amino acids 372 to 380) within the primary structure of 297-VlsE as opposed to that
of B31-VlsE. Murine antibodies were consistently developed against the C-terminal re-
gion during the entire infection period as reactivity was detected in all mouse sera taken
at day 28 and day 70 p.i. This fully supports the previous findings that the C-terminal
invariable domain is highly immunodominant [85] but shows limited antigenic conser-
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vation among B. burgdorferi strains [86]. It was previously shown that the C-terminal do-
main sequences of 11 B. burgdorferi strains were not identical to the C-terminal sequence
of the B31 strain [86]. Likewise, due to a high degree of divergence with 46% identity and
53% similarity between B31-VlsE and 297-VlsE [66], strong antibody reactivity was pre-
dicted only to IR1 of 297-VlsE. Finally, no significant difference between the reactivities
of day 28 and day 70 antibodies to the primary structures of translated cassettes vls2 to
vls16 (vls2-vls16) [67] was identified.
Similar to computational mapping of VlsE epitopes, identified peptides were also
mapped to decorin-binding protein A (DbpA), decorin-binding protein (DbpB), and P35.
These B. burgdorferi surface proteins were shown to be immunogenic and afforded pro-
tection in mice against B. burgdorferi infection [87, 88, 89]. Consistently, no significant
difference in antibody reactivities to contiguous epitopes of these immunogenic proteins
was detected between day 28 and day 70 serum samples (Figures 3.4, 3.5 ).
3.6.6 Conclusion
In this study, mimotope profiles derived from day 28 and 70 mice serum samples
were compared to each other. Since mimotopes are peptides that may mimic both contin-
uous and discontinuous antigens of a different nature (e.g., proteins, polysaccharides, and
lipids), the global mimotope comparison considered a variety of B. burgdorferi epitopes,
including lipid and carbohydrate epitopes. However, the comparison revealed no major
difference in antibody repertoires between the two time points of infection. Similarly, no
significant changes were identified between the two antibody repertoires when identi-
fied mimotopes were mapped against primary structures of VlsE, DbpA, DbpB, and P35.
Given, however, that many antibody epitopes of native proteins are discontinuous, the
mapping inherently underestimated repertoires of antibody developed to conformational
epitopes of these B. burgdorferi surface proteins. Moreover, the BLAST-based analyses of
antibody repertoires missed mimotopes that mimicked lipid and carbohydrate epitopes.
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Figure 3.4 Epitope mapping of non-VlsE surface proteins of Borrelia burgdorferi B31.
Heat maps generated from in silico prediction of anti-297 antibody reactivity to the pri-
mary structure of decorin-binding protein A (DbpA), decorin-binding protein B (DbpB),
and P35 (panels A, B, and C, respectively). Anti-297 sera were harvested from Bb-infected
C3H mice at day 28 and 70 post infection (5 animals per time point).
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Figure 3.5 Epitope mapping of non-VlsE surface proteins of Borrelia burgdorferi 297.
Heat maps generated from in silico prediction of anti-297 antibody reactivity to the pri-
mary structure of decorin-binding protein A (DbpA), decorin-binding protein B (DbpB),
and P35 (panels D, E, and F, respectively). Anti-297 sera were harvested from Bb-infected
C3H mice at day 28 and 70 post infection (5 animals per time point).
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PART 4
RNA-SEQ DATA PROCESSING FOR IMMUNE RESPONSE ANALYSIS
4.1 Introduction
RNA-Seq is an approach to transcriptome profiling using NGS technologies. The
transcriptome is the complete set of transcripts in a cell, and their quantity, for a specific
developmental stage or physiological condition. RNA-Seq is the first sequencing-based
method that allows the entire transcriptome to be surveyed in a very high-throughput
and quantitative manner [20]. Depending on whether there is a disease in an organism
or not, the transcriptional activity of genes involved in immune response is different.
One particularly powerful advantage of RNA-Seq is that it can capture this difference.
Although, like other high-throughput sequencing technologies, RNA-Seq requires devel-
opment of special methods for data analysis. Many variations of RNA-seq protocols and
analyses have been published, but there is still no optimal pipeline.
In this work, we developed a pipeline for whole transcriptomic analysis of well con-
trolled systems of rubella infected cells. Rubella virus is a small enveloped virus with a
positive single-strand RNA genome of 9.7 kb from the family Togaviridae, genus Rubivirus.
Rubella is an important human pathogen because of its ability to cross placenta and estab-
lish persistent infection in a fetus causing miscarriage, stillbirth or multiple birth defects
called congenital rubella syndrome. This syndrome is only associated with rubella in-
fections during the first trimester of pregnancy. There is a vaccine from rubella. Live
attenuated vaccine RA27/3, which is currently used by the majority of the countries, in-
duces life-long immunity and highly effective in preventing post-natal rubella infection
and congenital rubella syndrome. Using RNA-seq technology, we compared innate an-
tiviral responses induced by wild type rubella virus isolates and RA27/3 vaccine strain
in primary cultures of human umbilical vein endothelial cells (HUVEC).
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4.2 Library preparation and sequencing
RNA extracted from infected cells are assessed using Bioanalyzer (Agilent Technolo-
gies). The quantity of total RNA is also measured using Qubit fluorometer (Thermo
Fisher). Each sample is spiked with Control RNA developed by External RNA Controls
Consortium (ERCC; Thermo Fisher) prior to ribosomal RNA depletion (NEB).
Strand-specific library is prepared using the NEBNext@ UltraTM Directional RNA
Library Prep Kit for Illumina (NEB). Quantity and quality of each library is assessed by
Bioanlyzer, Qubit and real-time PCR (NEBNext@ Library Quant Kit for Illumina). The
library is sequenced using Illumiina MiSeq. As result, we obtain paired-end raw reads.
4.3 Differential gene expression analysis of RNA-seq data
We proposed the following pipeline for whole transcriptomic analysis for rubella
virus infected cells:
1. Quality control of paired-end reads using Sickle [90]. Sickle is a windowed adap-
tive trimming tool for FASTQ files using quality. It uses sliding windows along
with quality and length thresholds to determine when quality is sufficiently low to
trim the 3’-end of reads and also determines when the quality is sufficiently high
enough to trim the 5’-end of reads. It will also discard reads based upon the length
threshold.
2. Trimming adapters using Cutadapt [91]. The tool finds and removes adapter se-
quences, primers, poly-A tails and other types of unwanted sequence from high-
throughput sequencing reads.
3. Mapping trimmed reads to human genome using TopHat2 [92]. The tool is a fast
splice junction mapper for RNA-Seq reads. It aligns RNA-Seq reads to mammalian-
sized genomes using the ultra-high throughput short read aligner Bowtie2 [93], and
then analyzes the mapping results to splice junctions between exons.
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4. Counting reads aligned to human genes using htseq-count tool [94]. Given a file
with aligned sequencing reads and a list of genomic features - genes, a task was to
count how many reads map to each feature. In the case of RNA-Seq, each gene is
considered as the union of all its exons.
5. Finding biological replicates outliers. The read counts for all replicates should be
well correlated with each other. Although, there is no specific threshold for correla-
tion. Pearson correlation can be used in this case. A replicate that is different from
other replicates should be disregarded.
6. Finding genes deferentially expressed in samples under different conditions. EdgeR
[95] tool for finding differentially expressed genes are applied. EdgeR is a differen-
tial expression analysis of RNA-seq expression profiles with biological replication.
It implements a range of statistical methodology based on the negative binomial
distributions, including empirical Bayes estimation, exact tests, generalized linear
models and quasi-likelihood tests. EdgeR requires biological replicates. For experi-
ments without replicates DEGseq [96] tool can be used.
4.4 Results
In this work we compare cells in different conditions: uninfected HUVEC cells,
rubella wild virus (DeZhou strain) infected cells, rubella vaccine virus (RA27/3 strain) in-
fected cells. All RNAs were obtained from cells harvested 2, 7 and 14 days after infection.
The goal was to trace the development of infection over time, compare one condition in
different days, and compare uninfected cells with infected cells and wild rubella infected
cells with vaccine infected cells.
For every condition in each time point we had 6 biological replicates. Outliers in all
groups of replicates were found using pairwise Pearson correlation. We noticed that each
group of replicated were divided into two highly correlated (>0.9) groups. The correla-
tion between those two groups was usually less that 0.85. Table shows correlation be-
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tween replicates for wild rubella infected cells on day 7. Bold font represents correlation
greater than 0.9. Replicates 1,2 and 3 form one highly correlated group, and replicates 4,5
and 6 form another group. Differential gene expression analysis was performed between
conditions separately for each highly correlated replicate group.
Table 4.1 Pairwise Pearson correlation between biological replicates for wild rubella in-
fected cells on day 7. Bolt text represents correlation greater than 0.9
Biological replicates re
pl
ic
at
e_
1
re
pl
ic
at
e_
2
re
pl
ic
at
e_
3
re
pl
ic
at
e_
4
re
pl
ic
at
e_
5
re
pl
ic
at
e_
6
replicate_1 1 0.975 0.957 0.675 0.785 0.719
replicate_2 0.975 1 0.959 0.600 0.725 0.652
replicate_3 0.957 0.959 1 0.739 0.842 0.788
replicate_4 0.675 0.600 0.739 1 0.966 0.979
replicate_5 0.785 0.725 0.842 0.966 1 0.992
replicate_6 0.719 0.652 0.788 0.979 0.992 1
As results, there were identified 33 differentially expressed (DE) genes in wild rubella
infected cells between days 2 and 7, and 13 DE genes between days 2 and 14. 5 DE
genes were identified for vaccine infected cells between days 2 and 7. 180 DE genes were
identified between uninfected cells and wild rubella infected cells on day 2. 152 DE genes
were identified between uninfected cells and vaccine rubella infected cells on day 2. 115
DE genes were identified between uninfected cells and wild rubella infected cells on day
7. 153 DE genes were identified between uninfected cells and vaccine rubella infected cells
on day 7. No significant difference were detected between uninfected cells and infected
cells on day 14 and there was no difference between vaccine and wild type rubella on any
time point.
70
PART 5
FUTURE WORK
We plan to apply pathways analysis to RNA-seq rubella data.
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